Decheng Capital
Decheng Capital, based in California, backs life sciences and healthtech startups from Pre-Seed to Series B, with a specialist style and notable investments like GRAIL and Adaptive Biotechnologies.
Who you would pitch at Decheng Capital
12 people on the investing team, 7 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.
Check size not reported yet.
Bars: how many firms in the atlas report each band. Highlighted: this firm.No recent activity since September 2026. Quiet does not mean closed.
Weekly count of activity updates. Activity is not a confirmed deal.Notable investments
In their words
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAlert me when Decheng Capital is active
One email when this firm shows new activity. Nothing else.
Firms like Decheng Capital
On these lists
Questions
What stage does Decheng Capital invest in?
Decheng Capital reports entry at pre-seed, seed, series a, series b.
How much does Decheng Capital invest?
Decheng Capital has not reported a check size.
Does Decheng Capital lead rounds?
Decheng Capital has not reported a lead preference.
Who are the partners at Decheng Capital?
Min Cui (Founder & Managing Director), Peter Colabuono (Managing Director), Victor Tong Jr. (Managing Director), Dayton Misfeldt (Partner), Qiang Xu (Partner), Tony Tong (Partner).
Is Decheng Capital active right now?
No recent activity since September 2026.
Work at Decheng Capital? Claim or correct this profile.